Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon contact icon menu icon
Medicilon Logo
|
search icon close search icon contact icon menu icon
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Join Medicilon at the 22nd San Diego Biopharma Conference (SABPA 2024)

2024-09-24
|
Page View:

1.png

22nd San Diego Biopharma Conference (SABPA 2024)

Join Medicilon at the 22nd San Diego Biopharma Conference in the beautiful San Diego. This time, you can not only visit our table, but also focus the speech “Challenges of ADC Preclinical DMPK and Safety Evaluation” by President of Medicilon USA Corp., Dr. Qingcong Lin.

Date: October 5, 2024, 9:00 am - 5:00 pm

Location: Hilton San Diego/Del Mar 15575 Jimmy Durante Boulevard Del Mar, CA 92014

Dr.Lin.png

Agenda

1.png

About 22nd San Diego Biopharma Conference

The SABPA San Diego BioPharma Conference promises to be a groundbreaking event in the field of biotechnology and pharmaceuticals. The conference will bring together both academia and industry leaders, researchers, and visionaries from around the world to share their insights, latest discoveries and innovations.

This gathering brings together exceptional experts and leaders in both academia and industry to explore the latest breakthroughs, innovations, and opportunities in the field. The conference program boasts a notable lineup of top-level executives, distinguished scientists, and successful entrepreneurs. Topics include in vivo cell engineering and gene editing, protein homeostasis in neurodegeneration, histidine phosphorylation in cancer therapy, the establishment of biotech start-ups within venture-funded incubators and more. This event presents a unique opportunity to acquire knowledge, expand professional networks, and actively contribute to the ongoing transformation within the bio-pharmaceutical industry.

About Medicilon

Medicilon is a leading global integrated pharmaceutical R&D service contract research organization (CRO), providing a full range of one-stop preclinical R&D services, in compliance with Chinese and international regulatory filing standards, to pharmaceutical companies and research institutions world-wide. With our experience in serving domestic and foreign biomedical industries, we have built an integrated platform covering key technologies in drug discovery, pharmaceutical research, and preclinical research, to provide a comprehensive preclinical R&D service for the global biomedical industry.

20 Years of Excellence
500+ IND Approved by FDA, NMPA, EMA, and TGA

2000+ Active Clients Worldwide
2600+ Scientists & Research Staff
85,000+ m2 Lab Space

At Medicilon, we are dedicated to support our clients develop their research and discovery programs from initial concept through the IND filing phase. Our services span across medicinal chemistry, biology, API, CMC, formulation, and preclinical studies. We provide flexible business models, including stand-alone Fee for Services (FFS) and fully integrated FTE services. In addition, our facilities are GLP/GMP compliant, US-FDA, China NMPA and AAALAC accredited. All study reports can be presented in SEND format, supporting dual filing of IND applications in the US, EU, and China.

Services and Solutions

Drug Discovery

Chemistry

Biology

Early DMPK

CMC Services

DS/API/DP

CMC Research

Preclinical Research

Pharmacology

Pharmacodynamics

Pharmacokinetics

Drug Safety Evaluation

Bioanalysis

One-stop Integrated Services Platform

ADC R&D Service Platform

Antibody R&D Service Platform

PROTAC R&D Service Platform

Cell & Gene Therapy R&D Service Platform

Nucleic Acid Drugs R&D Service Platform

Peptide Drug Conjugate (PDC) R&D Service Platform

Synthetic Biology——Enzyme Catalytic Platform

Synthesis Biology——Peptide Drug Discovery Service Platform

NanoString nCounter Detection Platform

Flow Cytometry Technology Platform

Drug Routes of Administration Platform

Ophthalmology Platform

Inhalation drug R&D platform

Skin Topical Preparation R&D Platform

Preclinical Tumor Pharmacodynamic Services Platform

Preclinical Large Animal Pharmacodynamic Research Service Platform

Preclinical Non-tumor Pharmacodynamic Services Platform

……

#SABPA #Medicilon #Drugdiscovery #Preclinical

Meet with Medicilon
Subject丨SABPA 2024

Share:
Return
Relevant newsOnline registration
Company*
Name*
Work Email*
Title*
Verification Code*
Click to switch
Relevant newsRelevant news